SSSoumitra SamantaMSc, MTech, PhDSlideset26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Integration of Machine Learning for Predictive Pharmacometric Assessments - Soumitra SamantaView Slideset
CVFCourtney V. FletcherPharmDVideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Charles Boucher Memorial Lecture: Updates on Antiretroviral Penetration in Sanctuary Sites - Courtney V. FletcherView Video
AvDAnnette von DelftMD, DPhilVideo26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Protease Inhibitor for Pandemic Preparedness - Annette von DelftView Video
ERElias RosenPhDVideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #21 Longitudinal Monitoring of Cabotegravir and Rilpivirine Exposure from Hair Strand Concentrations - Elias RosenView Video
ERElias RosenPhDSlidesetHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #21 Longitudinal Monitoring of Cabotegravir and Rilpivirine Exposure from Hair Strand Concentrations - Elias RosenView Slideset
VideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #20 An Enzymatic Assay with Lateral Flow Readout for Measurement of Tenofovir Diphosphate and Long-Term HIV Medication Adherence - Carrie LinView Video
SlidesetHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #20 An Enzymatic Assay with Lateral Flow Readout for Measurement of Tenofovir Diphosphate and Long-Term HIV Medication Adherence - Carrie LinView Slideset
VideoHIVViral Hepatitis and Liver Disease26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #19 Assessing ChatGPT’s Capability in Understanding and Reporting Antiretroviral Therapy Drug-Drug Interaction Effects: Quantitative and Qualitative Results from the ACCURATE-DDI Study - Erin ReadyView Video
SlidesetHIVViral Hepatitis and Liver Disease26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #19 Assessing ChatGPT’s Capability in Understanding and Reporting Antiretroviral Therapy Drug-Drug Interaction Effects: Quantitative and Qualitative Results from the ACCURATE-DDI Study - Erin ReadyView Slideset
JCJon CollinsPharmDVideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #17 Lack of Clinically Significant Drug–Drug Interactions Between the Third-Generation Integrase Strand Transfer Inhibitor VH4524184 (VH-184) and Combined Oral Contraceptives - Jon CollinsView Video
JCJon CollinsPharmDSlidesetHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #17 Lack of Clinically Significant Drug–Drug Interactions Between the Third-Generation Integrase Strand Transfer Inhibitor VH4524184 (VH-184) and Combined Oral Contraceptives - Jon CollinsView Slideset
AOAndrew OwenBSS, MSC, PhD, FSBVideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #35 Can Low-Cost Oral Alternatives Be Used in Place of Oral Lenacapavir When Initiating Long-Acting Lenacapavir PrEP in Low- and Middle-Income Countries? - Andrew OwenView Video
